Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity

Karin Zins(Medical University of Vienna), Seyedhossein Aharinejad(Medical University of Vienna)

Journal of Translational Medicine

November 27, 2013

10.1186/1479-5876-11-295

Cited by 67

Related Papers

A Rac1/Cdc42 GTPase-Specific Small Molecule Inhibitor Suppresses Growth of Primary Human Prostate Cancer Xenografts and Prolongs Survival in Mice

|PLoS ONE|2013|95

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes

|Oncotarget|2018|36